|
|
||||||||
Lymphocyte Cell Biology Section, Arthritis and Rheumatism Branch, National Institute of Arthritis Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The phosphorylated receptor is also recognized by the adapter molecule Shc. Shc in turn becomes phosphorylated, allowing the recruitment of another adapter protein Grb2 and the guanosine nucleotide exchange factor SOS, which mediate the activation of the Ras/Raf/mitogen-activated protein kinase (MAPK) pathway 11, 12 . IL-2 also activates phosphatidylinositol 3'-kinase (PI 3'-kinase) 13, 14 and this is also thought to contribute to MAPK activation 15 . Neither the mechanism by which PI 3'-kinase activation occurs nor the steps by which PI 3'-kinase activation leads to MAPK activation have at present been clearly defined.
IL-2 and IL-4 have been reported to induce the phosphorylation of cytosolic docking proteins such as insulin receptor substrate (IRS-1) and IRS-2 16 . With IL-4, it is thought that the phosphotyrosine binding domain of IRS-1 and IRS-2 binds the phosphorylated receptor at Tyr497 and PI 3'-kinase binds phosphorylated IRS-1 or IRS-2. It is still not clear whether IL-2-dependent activation of MAPK involves IRS molecules, although it has alternatively been suggested that PI 3'-kinase binds directly to the IL-2 receptor 17 .
For transmembrane receptor tyrosine kinases, it appears that yet another means of MAPK activation do exist. With the platelet-derived growth factor ß receptor, it has been demonstrated that the SH2 containing phosphatase (SHP-2), can bind to the receptor and act as an adapter between the receptor itself and the Grb2-SOS complex 18, 19 . Recently, it has been shown that SHP-2 is also phosphorylated in response to IL-2 20, 21 and that IL-2 stimulation induces SHP-2 association with the p85 subunit of PI 3'-kinase and Grb2 22 . Notably, we also showed that SHP-2 is important in IL-2-dependent MAPK activation, because catalytically inactive SHP-2 blocked the IL-2 induced activation of MAPK. Moreover, SHP-2 expression also amplified STAT-dependent transcriptional activation. Thus, as with growth factor receptors, SHP-2 may be important in coupling the IL-2 receptor to MAPK activation. The mechanism by which this occurs, however, is unclear.
To better understand how SHP-2 positively regulates MAPK in IL-2 signaling, we searched for SHP-2-associated proteins that became phosphorylated in response to IL-2 stimulation. Here, we describe a substrate that was found to be tyrosine phosphorylated in response to IL-2 and was associated with SHP-2, PI 3'-kinase, and Grb2. Importantly, we demonstrate that p98 phosphorylation was dependent on the presence of the IL-2-activated Janus kinase, JAK3. Taken together, our results suggest that p98 may serve an important role as an adapter molecule, facilitating the activation of a variety of signaling pathways induced by IL-2.
| Materials and Methods |
|---|
|
|
|---|
Human IL-2 and IL-4 were provided by Dr. C. Reynolds (National
Cancer Institute, Frederick, MD) IL-7, IL-10 and IL-12 were purchased
from R&D System (Minneapolis, MN), IFN-
/ß was purchased from
Genzyme (Cambridge, MA). The following Abs were purchased:
antiphosphotyrosine Ab (Py-plus Mixture) (Zymed, San Francisco, CA);
anti-PI 3'-kinase (Upstate Biotechnology, Lake Placid, NY),
anti-GRB2, and anti-SHP-2 (Santa Cruz Biotechnology, Santa
Cruz, CA); and mouse monoclonal anti-PTP1D (SHP-2) (Transduction
Laboratories, Lexington, KY). Endoglycosidase
F/N-glycosydase F was purchased from Boehringer Mannheim
(Indianapolis, IN).
Cell culture
Human PBMC from peripheral blood of healthy donors were prepared as previously described (97% CD3+) 23 . The human NK cell line NK3.3 was kindly provided by Dr. J. Kornbluth (Arkansas Cancer Research Center, Little Rock, AR) and cultured as described 23 . Before stimulation, both T cells and NK3.3 were washed in CO2-acidified RPMI 1640 and rested for 24 h in RPMI 1640 containing 1.5% BSA.
Immunoprecipitation, immunoblotting, and deglycosylation
After resting, cells were resuspended in 1 ml of medium (3
x 107 NK3.3 cells, 5 x 107 T cells),
incubated at 37°C and stimulated with IL-2 (1000 IU/ml), IL-4 (1000
IU/ml), IFN-
/ß (1000 IU/ml), IL-7 (10 ng/ml), IL-10 (10 ng/ml), or
IL-12 (10 ng/ml) for the indicated times. After stimulation, cells were
washed once in PBS and lysed in buffer containing 0.5% Triton X-100,
50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 2 mM EDTA, 200 µM
Na3VO4, 10 µg/ml aprotinin, 10 µg/ml
leupeptin, and 2.5 µM p-nitrophenyl
p-guanidinobenzoate on ice for 30 min. Immunoprecipitation,
PAGE, and immunoblotting were performed as described previously 3 .
Proteins were detected by enhanced chemiluminescence (LumiGLO,
Kirkegaard & Perry Laboratories, Gaithersburg, MD). Deglycosylation
experiments were performed according to Kharitonenkov et al. 24 .
Briefly, immunoprecipitates were boiled for 5 min in buffer containing
1% SDS. They were then suspended in 500 µl of deglycosylation buffer
(40 mM potassium phosphate (pH 7.0), 20 mM EDTA, 1% 2-ME, 1% Triton
X-100) with 0.5 U of endoglycosidase F/N-glycosidase F and
incubated at 37°C for 18 h. PAGE and immunoblotting were
performed as described above.
| Results |
|---|
|
|
|---|
As previously reported, SHP-2 is phosphorylated in response to
IL-2 stimulation 20, 21 . Interestingly, SHP-2 itself was not the only
phosphoprotein found in SHP-2 immunoprecipitates from freshly isolated
T cells. In addition to phosphorylation of SHP-2, we also noted a
prominent phosphorylated substrate with an apparent molecular
mass of
98 kDa that was coimmunoprecipitated with SHP-2 (Fig. 1
A, lane 2). We also noticed
the presence of a band at
130 kDa that was weakly constitutively
phosphorylated in resting T cells and was further phosphorylated after
IL-2 stimulation. Notably, other cytokines, including those that also
activate JAK3 (IL-4 and IL-7), did not induce SHP-2 phosphorylation.
Furthermore, the cytokines that failed to induce SHP-2 phosphorylation
also did not induce p98 phosphorylation. To confirm that equal amounts
of SHP-2 were immunoprecipitated in the different samples, the filter
was reblotted with anti-SHP-2 (Fig. 1
A, lower panel).
The specificity of the immunoprecipitated bands was verified by
immunoprecipitating with a nonimmune control serum (Fig. 1
A,
lanes 7 and 8).
|
/ß did not induce SHP-2 or p98 phosphorylation (Fig. 1
/ß) or STAT6 (for IL-4) (data not shown).
A time-course experiment (Fig. 1It should be noted that because p98 was detected in SHP-2 immunoprecipitates, we cannot distinguish at present whether p98 itself is inducibly or constitutively phosphorylated or whether its association with SHP-2 is regulated by IL-2 stimulation; such experiments will require specific p98 reagents. However, because SHP-2 has SH2 domains, it is plausible to speculate that the association between SHP-2 and p98 might be phosphotyrosine dependent. Thus p98 might serve as a phosphorylated docking protein similar to IRS proteins. We therefore sought to analyze this phosphoprotein in greater detail.
IL-2 induces the association of p98 with PI 3'-kinase
In our previous study, we observed that IL-2 induced association
of SHP-2 with PI 3'-kinase. We speculated that one way this might occur
would be if SHP-2 and PI 3'-kinase both bound p98. Therefore, we next
investigated whether a 98-kDa phosphoprotein could also be detected in
association with the p85 subunit of PI 3'-kinase from IL-2-stimulated
cells. To this end, NK3.3 cells were stimulated with IL-2 or IL-4 and
immunoprecipitated with anti-p85 antiserum. As shown in Fig. 2
A, we observed a number of phosphorylated proteins that
coimmunoprecipitated with PI 3'-kinase. Importantly, a band at
98
kDa was present in IL-2 stimulated cells but not in IL-4 stimulated
cells. The IL-4 treatment, however, was able to induce the
phosphorylation of a molecule with apparent molecular mass of 180 kDa,
which was presumably IRS-1 (lanes 4 and 5)
indicating that IL-4 did induce substrate phosphorylation in these
cells. Equivalent amount of loading was confirmed by reprobing the
filter with anti-p85 antiserum (Fig. 2
A, lower
panel).
|
IL-2 induces the association of p98 with Grb2
These results were consistent with a model in which p98 might
serve as an adapter/docking molecule in IL-2 signaling, analogous to
the role of IRS-1 or IRS-2 in IL-4 such that SHP-2 and PI 3'-kinase
both bind p98 upon IL-2 stimulation. Because we had previously
demonstrated 16 that SHP-2 was also associated with Grb2 in
IL-2-stimulated cells, we next investigated whether p98 could also be
observed in Grb2 immunoprecipitates after IL-2 stimulation. Several
phosphophorylated bands were observed in lysates of NK3.3 cells after
IL-2 stimulation (Fig. 3
A),
the adapter molecule Shc being readily recognizable (lower arrow). In
addition, as already noted in SHP-2 and PI 3' kinase immunoprecipitates
from IL-2 stimulated cells, we detected a broad tyrosine-phosphorylated
band that migrated at
98 kDa, phosphorylation of which was maximal
at
5 min and greatly diminished by 30 min. The phosphorylation of
this 98 kDa was not observed when cells were stimulated with either
IL-4, IL-10, IL-12, or IFN-
/ß, despite the fact that Grb2 was
equally immunoprecipitated from these cells (Fig. 3
A, lower
panel). To better compare the pattern of IL-2-induced
phosphoproteins associated with Grb2 and PI 3'-kinase, we also used a
712.5% polyacrylamide gradient gel that allowed a better separation
of proteins. As shown in Fig. 3
B, we found a similar 98-kDa
phosphoprotein associated with both PI 3'-kinase and Grb2.
|
Thus our data indicated that SHP-2, PI 3'-kinase, and Grb2 all
coprecipitated a 98-kDa phosphoprotein. Although it was phosphorylated
by the same restricted stimulus (IL-2, but not other cytokines) with
the same kinetics and had a similar migration in polyacrylamide gels,
the SHP-2, PI 3'-kinase, and Grb2-associated p98 polypeptides might
nonetheless have had no relationship to one another. To better define
the nature of the p98 phosphoprotein found in the immunoprecipitates,
we next performed sequential immunodepletion experiments. That is, IL-2
stimulated cells were lysed and extensively depleted with PI 3'-kinase
antiserum or SHP-2 antiserum followed by immunoprecipitation with
either PI 3'-kinase and SHP-2 (Fig. 4
A); SHP-2 and PI 3'-kinase
(Fig. 4
B); or PI 3'-kinase and Grb-2 (Fig. 4
C).
We found that the SHP-2-associated p98 as well as the Grb2-associated
p98 were greatly diminished after p85 immunodepletion (Figs. 4
A, lane 8 and 4C, lane 8,
respectively). Similarly, when lysates were immunoprecipitated with
SHP-2 antiserum the PI 3'-kinase-associated p98 was also greatly
reduced (Fig. 4
B, lane 8). These data strongly suggest that
SHP-2, PI 3'-kinase, and Grb-2 are indeed associated with the same
98-kDa phosphoprotein and apparently form a multipartite complex; i.e.,
IL-2 stimulation results in the formation of a single complex
comprising all these molecules. However, because some residual p98 was
still detected in the different immunoprecipitates despite the
extensive preclearing, p98 may also participate in distinct complexes
with SHP-2, PI 3'-kinase, and Grb2 individually.
|
Recently, a new class of transmembrane glycoproteins named SHPS or
SIRPs that associate with SHP-1 and SHP-2 has been identified 24, 25 .
Moreover, SIRP1-
has been shown to be phosphorylated in response to
growth hormone, a cytokine that is related in a number of respect to
IL-2. To clarify whether p98 was a member of this family, we performed
an in vitro deglycosylation of SHP-2 and PI 3'-kinase
immunoprecipitates because the mobility of SIRP1-
is greatly altered
by this treatment 24, 26 . However, as shown in Fig. 5
, deglycosylation did not affect the
mobility of p98 in either SHP-2 or PI 3'-kinase immunoprecipitates. In
contrast, enzymatic treatment of immunoprecipitated IL-2R ß-chain, a
known glycosylated transmembrane protein, clearly altered its
migration, indicating that the treatment was indeed effective. These
results indicate that p98 is not a glycosylated molecule and therefore
not likely to be a member of the SHPS/SIRP family. Moreover, we were
unable to detect any p98 or SHP-2 association with the IL-2R ß-chain,
suggesting that the p98 complex may not directly bind to the IL-2R.
|
Because we have previously reported that JAK3 is important for
IL-2-induced association of SHP-2 with Grb2 and PI 3'-kinase 22 , we
next investigated whether JAK3 was required for the IL-2-induced
phosphorylation of p98. Cells from patients with JAK3-SCID were first
used to address this issue, but EBV-transformed B cells had
constitutive phosphorylation of various substrates in the same
molecular mass range of p98; this high level of basal phosphorylation
excluded the use these cells to test the requirement of Jak3 in
IL-2-induced p98 phosphorylation. We therefore used NIH 3T3 fibroblasts
stably transfected with the IL-2R subunits with or without JAK3 (NIH
3T3
ß
and NIH 3T3
ß
-JAK3) 5, 27 . In the absence of
JAK3, no phosphorylation of p98 was observed after IL-2 stimulation in
NIH 3T3
ß
cells (Fig. 6
, lane 2)
but was evident in SHP-2 immunoprecipitates from NIH 3T3
ß
-JAK3
cells (lane 4). The same JAK3-dependent phosphorylation of p98 was
observed in PI 3'-kinase (Fig. 6
, lanes 58) and Grb2
(lanes 912) immunoprecipitates, although for the
latter there was a higher phosphorylation in the absence of
stimulation. We interpret these data to show that IL-2-dependent p98
phosphorylation may be Jak3 dependent, however we recognize that IL-2
receptor transfected fibroblasts are an imperfect model system to test
this issue. Clearly a Jak3-deficient lymphoid line would be preferable
although, as mentioned, we were unable to use EBV-transformed B cell
lines from Jak3-deficient patients. The presence of SHP-2, PI
3'-kinase, Grb2-associated phosphoprotein in fibroblasts also suggests
that p98 may be a ubiquitous and not lineage specific, protein.
However, we have no direct evidence that the p98 found in murine
fibroblasts is related to the polypeptide present in lymphocytes.
|
| Discussion |
|---|
|
|
|---|
/ß. This polypeptide,
referred to as p98, was coimmunoprecipitated with SHP-2, and was the
most prominent phosphorylated band in SHP-2 immunoprecipitates. This is
important, because characterization of p98 may help to clarify how IL-2
signaling is linked to the MAPK and other pathways. We previously observed that IL-2 was able to induce the formation of SHP-2-PI 3'-kinase complex but we were not able to draw any conclusion on the nature of this complex. We therefore tested the possibility that the interaction could be mediated by a common intermediate. Interestingly, when we analyzed the phosphorylated substrates that were immunoprecipitated with the p85 subunit of PI 3'-kinase, we observed a major phosphorylated band that also comigrated with the SHP-2-associated phosphoprotein; indeed both polypeptides were phosphorylated with the same specificity and kinetics. More importantly, we found that preclearing with anti-PI 3'-kinase antiserum greatly diminished the SHP-2-associated p98, and the converse was also demonstrated to be true. Therefore, we hypothesize that the three molecules are part of a multiprotein complex. However, because we observed residual binding of p98 after extensive preclearing, the possibility also exists that p98 participates in complexes with each partner individually. This is in agreement with the fact that the consensus sequence for binding to the SH2 domains of SHP-2 and PI 3'-kinase p85 subunit are distinct. It is therefore tempting to speculate that SHP-2, p85, and possibly Grb2 bind to different phosphotyrosines on p98 and that p98 may function as an adapter protein.
We first considered that the SHP-2-associated p98 phosphoprotein seen
with IL-2 stimulation might be a member of the recently described
family of transmembrane glycoproteins with sequence homology to named
SHPS/SIRPs 24, 25 , as SIRP1
is phosphorylated in response to
growth hormone 26, 28 . However, the IL-2-dependent phosphoprotein p98
was not sensitive to deglycosylation treatment reducing the likelihood
that it is a member of this family.
DOS (daughter of sevenless) is a substrate of the Drosophila homolog of SHP-2, corkscrew, and its mammalian homolog is Gab1 30, 31, 33 . We also considered the possibility that p98 is Gab1 but we were unable to detect Gab1 phosphorylation after IL-2 stimulation; indeed Gab1 was poorly expressed in the NK3.3 cell line (data not shown). Thus we interpret our results to indicate that p98 is unlikely to be Gab1 or a SIRP family member.
Recently, other groups have described SHP-2-associated and PI
3'-kinase-associated phosphoproteins that migrate at
100 kDa after
cytokine stimulation 34, 35, 36, 37 . It is possible that the IL-2-activated
p98 molecule we describe here is identical or related to these other
proteins. It is notable that we found a p98-like molecule in
IL-2-stimulated fibroblasts suggesting that p98 might be an ubiquitous
protein that could play a role in signaling through a variety of
receptors.
It is also of interest that IL-4 failed to induce p98 phosphorylation despite the commonalities in IL-2 and IL-4 signal transduction and the fact that IL-4 induces IRS phosphorylation. Given that the biological effects of IL-2 and IL-4 clearly differ, it is clearly important to identify distinct elements in their receptor signaling pathways.
Mitogenic signal in response to IL-2 has been demonstrated to be dependent on the presence of JAK3 41 . Although our results, obtained in a nonlymphoid system, suggest that, JAK3 may be required for p98 phosphorylation. The exact role of Jak3 in p98 phosphorylation will clearly need to be revisited when specific p98 reagents become available. In conclusion, although the functions of SHP-2 and its substrates are still poorly defined, if p98 acts as a docking molecule similar to the IRS it may play critical role in IL-2-induced T cell proliferation analogous to the role of IRS in IL-4-dependent proliferation. The identification and cloning of this molecule will be important to assess the significance of the SHP-2/PI 3'-kinase/Grb2/p98 complex and in defining the role of these molecules in IL-2 actions.
Note added in proof.
Since the submission of this manuscript Gesbert et al. 42 described a similar phosphorylated substrate.
| Acknowledgments |
|---|
ß
cells. We are also indebted to
Dr. Elbert H. Chen for helpful suggestions and critical comments. | Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. John J. OShea, Building 10, Room 9N228, 10 Center Drive, MSC 1820, Bethesda, MD 20892-1820. E-mail address: ![]()
3 Abbreviations used in this paper: JAK, Janus Kinase; MAPK, mitogen-activated protein kinase; IRS, insulin receptor substrate; PDGF, platelet-derived growth factor ß; SHP-2, SH2-containing phosphatase; SHPS/SIRPs, SHP substrate/signal-regulatory proteins. PI 3'-kinase, phosphatidylinositol 3'-kinase. ![]()
Received for publication July 7, 1998. Accepted for publication November 11, 1998.
| References |
|---|
|
|
|---|
c chain for Janus kinase activation leading to T cell proliferation. Proc. Natl. Acad. Sci. USA 94:1878.
/ß-induced gene expression. J. Biol. Chem. 271:15862.This article has been cited by other articles:
![]() |
H. Zhang, D. M. Conrad, J. J. Butler, C. Zhao, J. Blay, and D. W. Hoskin Adenosine Acts through A2 Receptors to Inhibit IL-2-Induced Tyrosine Phosphorylation of STAT5 in T Lymphocytes: Role of Cyclic Adenosine 3',5'-Monophosphate and Phosphatases J. Immunol., July 15, 2004; 173(2): 932 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Smith, V. Patel, S. D. Seatter, M. R. Deehan, M. H. Brown, G. P. Brooke, H. S. Goodridge, C. J. Howard, K. P. Rigley, W. Harnett, et al. A novel MyD-1 (SIRP-1{alpha}) signaling pathway that inhibits LPS-induced TNF{alpha} production by monocytes Blood, October 1, 2003; 102(7): 2532 - 2540. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kashiwada, C. C. Giallourakis, P.-Y. Pan, and P. B. Rothman Immunoreceptor Tyrosine-Based Inhibitory Motif of the IL-4 Receptor Associates with SH2-Containing Phosphatases and Regulates IL-4-Induced Proliferation J. Immunol., December 1, 2001; 167(11): 6382 - 6387. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Moon and B. H. Nelson Phosphatidylinositol 3-Kinase Potentiates, but Does Not Trigger, T Cell Proliferation Mediated by the IL-2 Receptor J. Immunol., September 1, 2001; 167(5): 2714 - 2723. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Martino, J. H. Holmes IV, J. D. Lord, J. J. Moon, and B. H. Nelson Stat5 and Sp1 Regulate Transcription of the Cyclin D2 Gene in Response to IL-2 J. Immunol., February 1, 2001; 166(3): 1723 - 1729. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gadina, C. Sudarshan, R. Visconti, Y.-J. Zhou, H. Gu, B. G. Neel, and J. J. O'Shea The Docking Molecule Gab2 Is Induced by Lymphocyte Activation and Is Involved in Signaling by Interleukin-2 and Interleukin-15 but Not Other Common gamma Chain-using Cytokines J. Biol. Chem., August 25, 2000; 275(35): 26959 - 26966. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kong, C. Mounier, J. Wu, and B. I. Posner Epidermal Growth Factor-induced Phosphatidylinositol 3-Kinase Activation and DNA Synthesis. IDENTIFICATION OF Grb2-ASSOCIATED BINDER 2 AS THE MAJOR MEDIATOR IN RAT HEPATOCYTES J. Biol. Chem., November 10, 2000; 275(46): 36035 - 36042. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |